Literature DB >> 23681510

Organ selective regulation of sympathetic outflow by the brain Angiotensin system.

Rohit Ramchandra1, Song T Yao, Clive N May.   

Abstract

Angiotensin II (Ang II) has actions on the sympathetic nervous system both as a circulating hormone acting on the circumventricular organs and also as a neurotransmitter/ neuromodulator acting within the brain. Administration of Ang II into the cerebral ventricles has diverse effects on sympathetic nerve activity (SNA), causing an increase in cardiac and splanchnic and a decrease in renal SNA. Similar contrasting effects on cardiac and renal SNA are seen with administration of hypertonic saline, which is thought to act centrally through angiotensinergic pathways. In heart failure there is compelling evidence that central angiotensinergic mechanisms contribute to the increases in cardiac and renal SNA, which have numerous detrimental effects. Although there is evidence that Ang II regulates sympathetic activity, and contributes to excess SNA in disease, the exact sites in the brain at which Ang II acts to selectively control SNA to individual organs are not well defined.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23681510     DOI: 10.1007/s11906-013-0355-2

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  77 in total

Review 1.  Localization and function of angiotensin AT1 receptors.

Authors:  A M Allen; J Zhuo; F A Mendelsohn
Journal:  Am J Hypertens       Date:  2000-01       Impact factor: 2.689

2.  Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction.

Authors:  W Zhang; B S Huang; F H Leenen
Journal:  Am J Physiol       Date:  1999-05

3.  ANG II chronically supports renal and lumbar sympathetic activity in sodium-deprived, conscious rats.

Authors:  L Xu; V L Brooks
Journal:  Am J Physiol       Date:  1996-12

4.  Inhibition of renal sympathetic nerve activity of anesthetized rats by intracerebroventricular administration of angiotensin II.

Authors:  X J Jin; H Kannan; Y Hayashida; T Nakamura; H Higashino; H Yamashita
Journal:  J UOEH       Date:  1989-12-01

5.  Reversal of genetic salt-sensitive hypertension by targeted sympathetic ablation.

Authors:  Jason D Foss; Gregory D Fink; John W Osborn
Journal:  Hypertension       Date:  2013-02-04       Impact factor: 10.190

6.  Neurohumoral contributions to chronic angiotensin-induced hypertension.

Authors:  C A Bruner; G D Fink
Journal:  Am J Physiol       Date:  1986-01

Review 7.  Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: the altered inhibitory mechanisms.

Authors:  Y-F Li; K P Patel
Journal:  Acta Physiol Scand       Date:  2003-01

8.  Increased renal nerve activity in cardiac failure: arterial vs. cardiac baroreflex impairment.

Authors:  G F DiBona; L L Sawin
Journal:  Am J Physiol       Date:  1995-01

9.  Astrocytes synthesize angiotensinogen in brain.

Authors:  R L Stornetta; C L Hawelu-Johnson; P G Guyenet; K R Lynch
Journal:  Science       Date:  1988-12-09       Impact factor: 47.728

10.  Immunocytochemical localization of angiotensinogen in the rat brain.

Authors:  W G Thomas; C Sernia
Journal:  Neuroscience       Date:  1988-04       Impact factor: 3.590

View more
  2 in total

1.  Hepatic and renal mechanisms underlying the osmopressor response.

Authors:  Tu H Mai; Emily M Garland; André Diedrich; David Robertson
Journal:  Auton Neurosci       Date:  2017-01-27       Impact factor: 3.145

Review 2.  Angiotensin II and the Cardiac Parasympathetic Nervous System in Hypertension.

Authors:  Julia Shanks; Rohit Ramchandra
Journal:  Int J Mol Sci       Date:  2021-11-14       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.